MR-Evaluation of Renal Function-After-Pancreas-transplantation
MERFAP
1 other identifier
observational
40
1 country
1
Brief Summary
The purpose of this study is to evaluate the beneficial effect of pancreas transplantation for long term kidney function in patients undergoing single-pancreas transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 13, 2012
CompletedFirst Posted
Study publicly available on registry
February 23, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedFebruary 23, 2012
February 1, 2012
3 years
February 13, 2012
February 22, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Kidney function
Improvements in kidney function (GFR) and proteinuria after pancreas transplantation.
Within 3 years
Secondary Outcomes (1)
Kidney hemodynamics and oxygenation
Within 3 years
Study Arms (1)
Patients with pancreastransplantation
All patients undergoing pancreas transplantation.
Eligibility Criteria
Patients with diabetes mellitus
You may qualify if:
- Patients with diabetes mellitus
- Patients undergoing a pancreas transplantation
You may not qualify if:
- Patients undergoing a pancreas transplantation and a renal transplantation at the same time.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Uppsala, Uppsala County, 75185, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Per Liss, MD, PhD.
Uppsala University, Uppsala, Sweden
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
February 13, 2012
First Posted
February 23, 2012
Study Start
February 1, 2012
Primary Completion
February 1, 2015
Study Completion
August 1, 2015
Last Updated
February 23, 2012
Record last verified: 2012-02